businesspress24.com - AtmanCo Files Its Consolidated Financial Results for the First Quarter of 2013 and Presents a Summar
 

AtmanCo Files Its Consolidated Financial Results for the First Quarter of 2013 and Presents a Summary of Its Activities

ID: 1232033

(firmenpresse) - MONTREAL, QUEBEC -- (Marketwired) -- 05/30/13 -- AtmanCo Inc. ("AtmanCo" or the "Company") (TSX VENTURE: ATW) has filed its consolidated interim financial statements for the quarter ended March 31, 2013.

Highlights of the First Quarter of 2013

Activity Summary

During the first quarter of 2013, sales by the Company improved $235,222 over the quarter ended February 29, 2012. This increase is due to the reverse takeover as well as a sales augmentation in the human resources sector. AtmanCo increased its efforts with potential partners and customers to develop new markets, notably in Europe. In addition, the Atman Test was revised and translated into three additional languages, enabling the Company to reach the Portuguese, German and Dutch markets.

These international efforts ran concurrent to development initiatives closer to home, with AtmanCo announcing it had entered into a partnership with Canadian telecommunications leader Videotron for the use of the platform of psychometric tests developed by AtmanCo and the creation of corporate standards.

Excluding depreciation, the Company saw its gross margin increase by $170,000 over the comparable quarter.

The results for the quarter ended February 29, 2012 do not include the results associated with the Company's cyberhealth activities since the reverse takeover took place on October 18, 2012. Since quarters do not end on the same day, the Company used the fiscal period ended February 29, 2012 for analysis purposes as comparable quarter, given that these data are the most reflective of the current period.

Changes to the Board of Directors

In January 2013, the Company appointed Susan Kudzman as a board member of AtmanCo. In April 2013, Catherine Loubier left her position as a member of the AtmanCo Board of Directors.

The above data comprise a summary of highlights. For further information, please consult the Company's consolidated financial statements as well as the Management Report for the fiscal quarter ended March 31, 2013, at .





About AtmanCo

Field of human ressources

AtmanCo helps executives and managers recruit qualified human resources and place the right person in the right position. AtmanCo created the - a simple, accurate and scientifically proven psychometric test with four modules: At-Plus, At-Model, At-Matchand At-Team. Each test and its modules identify factors that shape an individual's personality and influence their performance. User-friendly and easy to use, these proven tools for developing human potential integrate easily into the recruitment, organizational evaluation, and talent management processes.

Field of cyberhealth

The Company's mission is to provide corporations as well as health and physical conditioning professionals with the means to enhance the value and efficiency of their customer services, to offer personalized corrective solutions for posture and physical condition, including exercise programs and eventually innovative orthoses destined to improve the well-being of people suffering from backaches or other musculoskeletal disorders and to improve people's physical and mental condition as well as their general health, by harnessing leading edge technologies in the fields of posture and biomechanics.

The Company stands out in its marketing approach via its Web site, direct sales and partner network. For further information, visit and sites.

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. There is a risk that expectations and forward looking statements will not prove to be accurate. Readers are cautioned not to place undue reliance on these forward looking statements as they involve risks and uncertainties, which could make actual results differ materially from those projected herein and depend on a number of factors including, but not limited to, no history of profitability, future financing, intellectual property and patents, key personnel, competitive marketplace, technology obsolescence, share price volatility and other risks detailed from time to time in the Company's filings. While AtmcanCo anticipates that subsequent events and developments may cause its views to change, AtmcanCo specifically disclaims any obligation to update these forward looking statements, unless obligated to do so by applicable securities laws.

The TSX Venture Exchange and its Regulatory Services provider (as per meaning assigned to this term in TSX Venture Exchange's policies) bear no liability as to the relevance or accuracy of this press release.



Contacts:
SOURCE:
AtmanCo Inc.
Michel Guay
President and CEO
514.935.5959 ext. 301


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  New European Phase II Trial to Test Immunovaccine's DPX-Survivac in Brain Cancer Patients
MethylGene to Present at the Jefferies 2013 Healthcare Conference
Bereitgestellt von Benutzer: Marketwired
Datum: 30.05.2013 - 06:00 Uhr
Sprache: Deutsch
News-ID 1232033
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

MONTREAL, QUEBEC


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 183 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"AtmanCo Files Its Consolidated Financial Results for the First Quarter of 2013 and Presents a Summary of Its Activities
"
steht unter der journalistisch-redaktionellen Verantwortung von

AtmanCo Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von AtmanCo Inc.



 

Who is online

All members: 10 566
Register today: 1
Register yesterday: 0
Members online: 0
Guests online: 87


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.